PSA RESPONSE TO NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IS A STRONG INDEPENDENT PREDICTOR OF SURVIVAL IN HIGH-RISK PROSTATE CANCER IN THE DOSE-ESCALATED RADIATION THERAPY ERA

PURPOSE: The aim of the study was to evaluate the prognostic value of prostate specific antigen (PSA) response to neoadjuvant androgen deprivation therapy (ADT) prior to dose-escalated radiation therapy (RT) and long-term ADT in high-risk prostate cancer. METHODS AND MATERIALS: We reviewed the chart...

Full description

Saved in:
Bibliographic Details
Main Authors: McGuire, Sean E., Lee, Andrew K., Cerne, Jasmina Z., Munsell, Mark F., Levy, Lawrence B., Kudchadker, Rajat J., Choi, Seungtaek L., Nguyen, Quynh N., Hoffman, Karen E., Pugh, Thomas J., Frank, Steven J., Corn, Paul G., Logothetis, Christopher J., Kuban, Deborah A.
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3840533/
https://ncbi.nlm.nih.gov/pubmed/23102837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.08.036
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items